
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Dec 2025 | $-0.50 | $-0.49 | +2.00% | Beat |
| Mar 2026 | $-0.55 | $-0.39 | +29.09% | Beat |
| Jun 2026 | $-0.46 | $-0.40 | +13.04% | Beat |
| Sep 2026 | $-0.45 | $-0.49 | -8.89% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Contineum typically reports earnings before the market opens, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-30 | +$1.37 (+9.53%) | $1.38 (9.60%) | -$0.26 (-1.65%) | $1.95 (12.41%) |
| 2026-05-05 | +$0.24 (+1.70%) | $0.89 (6.27%) | +$0.55 (+3.82%) | $1.32 (9.17%) |
| 2026-03-05 | -$1.05 (-7.07%) | $1.48 (9.96%) | +$0.07 (+0.51%) | $1.54 (11.19%) |
| 2025-10-30 | -$0.36 (-3.30%) | $0.50 (4.59%) | +$0.47 (+4.46%) | $0.65 (6.21%) |
| 2025-08-05 | +$0.20 (+3.45%) | $0.42 (7.24%) | +$0.33 (+5.50%) | $0.60 (9.97%) |
| 2025-05-14 | +$0.03 (+0.79%) | $0.68 (17.85%) | +$0.10 (+2.60%) | $0.47 (12.24%) |
| 2025-03-06 | +$0.34 (+5.57%) | $0.68 (11.15%) | +$0.33 (+5.12%) | $0.46 (7.14%) |
| 2024-11-06 | +$0.64 (+3.86%) | $0.66 (3.95%) | +$1.31 (+7.60%) | $1.38 (7.98%) |
| Avg Abs Move | 4.41% | 8.82% | 3.91% | 9.54% |
Contineum has exhibited volatile post-earnings price action, with an average absolute Day 0 move of 4.41% and Day +1 move of 3.91%. The most dramatic reaction came following the July 2026 report, when shares surged 9.53% on Day 0, though this was followed by a modest 1.65% decline the next session. The March 2026 report triggered a 7.07% decline on Day 0, while the most recent September 2026 report saw a relatively muted 3.30% drop.
The Day 0 range averages 8.82%, indicating substantial intraday volatility as investors digest results and management commentary. Day +1 ranges are even wider at 9.54%, suggesting that initial reactions often give way to reassessment as analysts publish notes and institutional investors adjust positions. The pattern shows that positive earnings surprises don't necessarily translate to sustained gains—the May 2026 beat produced only a 1.70% Day 0 move—while misses can be absorbed relatively well if accompanied by positive pipeline updates.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-30 | +9.53% | 9.60% | -1.65% | 12.41% |
| 2026-05-05 | +1.70% | 6.27% | +3.82% | 9.17% |
| 2026-03-05 | -7.07% | 9.96% | +0.51% | 11.19% |
| 2025-10-30 | -3.30% | 4.59% | +4.46% | 6.21% |
| 2025-08-05 | +3.45% | 7.24% | +5.50% | 9.97% |
| 2025-05-14 | +0.79% | 17.85% | +2.60% | 12.24% |
| 2025-03-06 | +5.57% | 11.15% | +5.12% | 7.14% |
| 2024-11-06 | +3.86% | 3.95% | +7.60% | 7.98% |
| Avg Abs Move | 4.41% | 8.82% | 3.91% | 9.54% |
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 16) |
| Expected Move | $0.55 (5.66%) |
| Expected Range | $9.22 to $10.32 |
| Implied Volatility | 185.45% |
The options market is pricing a 5.66% expected move by the November 20 expiration (16 days out), which sits below the historical average Day 0 move of 4.41% but well below the 8.82% average Day 0 range. This suggests options traders are anticipating moderately elevated volatility but not the extreme swings seen in some prior quarters. The expected move range of $9.22 to $10.32 implies the market sees roughly equal probability of upside and downside, consistent with the current uncertainty around the company's strategic pivot and cash burn trajectory.
| Metric | Value |
|---|---|
| Expected Move | ±5.66% ($0.55) |
| Upper Price Target | $10.32 |
| Lower Price Target | $9.22 |
| Days to Expiration | 16 days |
| Average Volatility | 185.45% |
Contineum currently carries a consensus rating that translates to Hold, with an average recommendation of 4.13 on the five-point scale. The breakdown shows 4 Strong Buys, 1 Moderate Buy, and 3 Holds, with no sell ratings among the eight analysts covering the stock. However, sentiment has deteriorated over the past month, with the average recommendation declining from 4.38 as one analyst downgraded from Strong Buy to Hold.
The average price target of $22.00 implies substantial upside of approximately 125% from current levels, with estimates ranging from a low of $14.00 to a high of $30.00. This wide range reflects deep disagreement about PIPE-791's probability of success and the appropriate risk discount for a single-asset story. The most bullish analysts, including JonesTrading with a $30 target, emphasize the validated LPAR1 mechanism and PIPE-791's differentiated profile. More cautious voices, like Baird's $14 target following its October downgrade, cite competitive concerns and the binary nature of the Phase 2 readout expected in 2028.
The deteriorating sentiment trend is notable: one month ago, the consensus was more bullish at 4.38, with 5 Strong Buys versus the current 4. Recent downgrades from Robert W. Baird (Outperform to Neutral, $19 to $14) and price target cuts from Stifel ($28 to $23) and Morgan Stanley ($18 to $17) reflect growing caution following the PIPE-307 failure and mixed signals from Bristol's competing ALOFT trial. Despite the pullback in targets, the consensus still implies meaningful upside, suggesting analysts believe the market has overreacted to near-term setbacks and that PIPE-791's potential in a large, underserved market justifies the current valuation.
The Barchart Technical Opinion currently shows an 88% Sell signal, strengthening from 100% Sell last week and 40% Sell a month ago. This represents a Strengthening trend in bearish momentum, with the signal direction indicating deteriorating technical conditions heading into earnings.
Timeframe Analysis:
Trend Characteristics: The Strong and Strengthening trend environment indicates building bearish momentum heading into earnings, with technical deterioration accelerating rather than stabilizing.
The stock is trading at $9.76, positioned above its 5-day ($9.55), 10-day ($9.07), and 20-day ($9.08) moving averages, suggesting a modest short-term bounce within a broader downtrend. However, the stock remains below all longer-term moving averages: the 50-day ($12.27), 100-day ($13.44), and 200-day ($13.52). This configuration—above short-term but below all intermediate and long-term averages—is characteristic of a bear market rally or dead-cat bounce rather than a genuine trend reversal.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $9.55 | 50-Day MA | $12.27 |
| 10-Day MA | $9.07 | 100-Day MA | $13.44 |
| 20-Day MA | $9.08 | 200-Day MA | $13.52 |
The technical setup heading into earnings is cautionary, with the stock trapped in a clear downtrend despite recent stabilization. The 28% gap between the current price and the 50-day moving average represents significant overhead resistance, while the clustering of the 50-, 100-, and 200-day averages in the $12-$14 range creates a formidable resistance zone. The strengthening sell signal and 100% bearish readings in both medium- and long-term timeframes suggest the path of least resistance remains lower absent a major positive catalyst. For bulls, a decisive break above the 20-day moving average with expanding volume would be the first sign of technical improvement, but the weight of evidence suggests traders should approach this earnings release with defensive positioning.